This is the 7th quarterly HIV Program report after implementation of the 2011 Integrated Clinical
HIV Guidelines in July 2011. A summary of the key achievements between January and March 2013
is provided below:
Scale‐up of integrated HIV services had reached the following number of sites:
825 static (607 within and 218 outside of health facilities) and 534 outreach HTC sites
655 (static) ART sites
580 PMTCT sites (Option B+)
602 Pre‐ART sites
590 sites with HIV‐exposed child follow‐up
460,559 persons were tested and counselled for HIV and 41,321 (9%) were HIV positive;
170,334 (37%) people tested for the first time.
127,167 (78%) of 163,522 women at ANC had their HIV status ascertained; 10,282 (8%) of
these were HIV positive. 102,506 (89%) of 114,376 women at maternity had their HIV status
ascertained; 8,306 (8%) of these were HIV positive.
26,881 patients started ART during this quarter; this is an 11% increase from the previous
quarter (24,168), probably related to the improved management of HIV test kit supplies.
422,866 patients were alive and on ART by end of March 2013; 84,499 (22%) of 390,576 on
first line adult regimens were on ART regimen 5A (tenofovir / lamivudine / efavirenz).
81%_ of adults and 78%__ of children were retained alive on ART at 12 months after ART
A total of 11,120 HIV positive pregnant women were on ART: 4,134 (37%) of these were
already on ART when getting pregnant and 6,986 (63%) started ART during
pregnancy/delivery. 6,773 (97%) of pregnant women started ART due to Option B+ (in WHO
clinical stage 1 or 2) and 213 (3%) due to a low CD4 count and/or WHO clinical stage 3 or 4.
An additional 2,279 breastfeeding women started ART due to Option B+ (in WHO clinical
stage 1 or 2).
6,695 (77%) of 8,648 women started under Option B+ were retained at 6 months after ART
initiation (6‐month retention outcomes were not available for some women, mainly at sites
with electronic data systems).
7,740 (8%) of infants discharged alive from maternity were known to be HIV exposed, 6,975
(90%) of these received ARV prophylaxis. 5,096 (73%) were enrolled in exposed child followup
before age 2 months.
A total of 10,319 HIV exposed children and 9,510 pre‐ART patients were enrolled for followup
in HIV Care Clinics (HCC) during this quarter.
195 medical staff were newly trained and certified in PMTCT/ART and an additional 23
medical records clerks were trained in M&E for the PMTCT/ART program this quarter. This
brings the total number trained in the 2011 guidelines to 5,711.
513 HTC counsellors and 1,239 HSAs at 152 facilities received mentoring for collection of
dried blood samples for Early Infant Diagnosis and documentation of results.
In preparation for a nationwide retraining of all HTC providers, 20 Master trainers were
trained in the HTC Skills Intensive Training curriculum, who in turn trained 197 trainers.
418 health workers and 182 support staff at 70 facilities in the SE Zone received clinical
mentoring in provision of PMTCT/ART. 45 of these health workers were in the intensive
phase, 223 in the continuation phase and 150 graduated from the mentoring program this